Novelties in the field of anti-infective compounds in 1999

被引：21

作者：

Bryskier, A ^{[1
]}

机构：

[1] Aventis Pharma, Infect Dis Grp, F-93235 Romainville, France

来源：

CLINICAL INFECTIOUS DISEASES | 2000年 / 31卷 / 06期

关键词：

D O I：

10.1086/317490

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

In 1999 the number of new compounds reported in the anti-infective field decreased significantly in comparison with previous years, especially for antifungals. The reported new compounds are mainly directed against Staphylococcus aureus isolates resistant to methicillin. Few derivatives were reported in the field of anti-infectives for gram-negative bacteria. At the moment, we are in a period of discovery as we await novel compounds that could issue from new engineering.

引用

页码：1423 / 1466

页数：44

共 208 条

[1] ALACRON T, 1999, 39 INT C ANT AG CHEM, P334
[2] IN-VITRO ACTIVITY OF NEW SULPHANILIL FLUOROQUINOLONES AGAINST STAPHYLOCOCCUS-AUREUS
ALLEMANDI, DA
ALOVERO, FL
MANZO, RH
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 34 (02) : 261 - 265
[3] ALLMAN GW, 1999, 39 INT C ANT AG CHEM, P338
[4] Engineering the specificity of antibacterial fluoroquinolones:: Benzenesulfonamide modifications at C-7 of ciprofloxacin change its primary target in Streptococcus pneumoniae from topoisomerase IV to gyrase
Alovero, FL
Pan, XS
Morris, JE
Manzo, RH
Fisher, LM
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) : 320 - 325
[5] [Anonymous], 39 INT C ANT AG CHEM
[6] ARMIGER YL, 1998, 38 INT C ANT AG CHEM, P254
[7] ASAKA T, 1999, 39 INT C ANT AG CHEM, P352
[8] ASAKA T, 1999, 39 INT C ANT AG CHEM, P353
[9] BACHOUAL R, 1999, 39 INT C ANT AG CHEM, P122
[10] BARBACHYN MR, 1999, 39 INT C ANT AG CHEM, P312

← 1 2 3 4 5 6 7 8 9 10 →